In this study, we demonstrated that the expression of TGF‐β is positively correlated with the EGFR expression in breast cancer tissues, and the increased levels of TGF‐β and EGFR are associated with the poor prognosis of patients with cancer. The gene discussed is EGFR; the disease is breast carcinoma.